Xortx Therapeutics Inc

CUSIP 98420Q306COMXRTXQ4 2025

Xortx Therapeutics Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Oct 27, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Oct 27, 2025	Lincoln Alternative Strategies LLC	13G	9.9%	572.5K	SEC
2	May 15, 2025	Armistice Capital, LLC	13G/A	5.0%	178.0K	SEC
3	Feb 14, 2025	Armistice Capital, LLC	13G	10.0%	346.8K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Drw Securities, LLC	193.6K	$108.8K
2	Two Sigma Securities, LLC	12.6K	$7.1K
3	Baader Bank Aktiengesellschaft	18.7K	$4.7K
4	Royal Bank Of Canada	4.1K	$2.0K
5	Ubs Group AG	1.4K	$787
6	Clearstead Advisors, LLC	277	$156